Literature DB >> 8495306

New technique to measure mucosal metabolism and its use to map substrate utilization in the healthy human large bowel.

M A Chapman1, M F Grahn, P Giamundo, P R O'Connell, D Onwu, M Hutton, J Maudsley, B Norton, J Rogers, N S Williams.   

Abstract

A new method of assessing substrate utilization in gastrointestinal mucosal specimens is described. Small human endoscopic biopsy specimens with wet weights ranging between 1.4 and 12.2 mg were used to quantify the oxidation of three metabolic substrates, glucose, glutamine and butyrate, through to carbon dioxide over a 2-h period. The technique proved to be reproducible and capable of distinguishing variations in mucosal metabolism between individuals (P < 0.0001 for each substrate). Results were similar to those obtained previously using human and rat colonocytes. To characterize the metabolism of the healthy large bowel, specimens were obtained from five regions in 15 patients who had a normal colonoscopic examination. The results show that butyrate is the preferred fuel source of large bowel mucosa, followed by glutamine, then glucose (P < 0.01). There was no significant regional variation in utilization of the three substrates between the five regions; with respect to glutamine, this is contrary to previous findings.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495306     DOI: 10.1002/bjs.1800800412

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

1.  The effects of glutamine on intestinal epithelial cell proliferation in parenterally fed rats.

Authors:  N Mandir; R A Goodlad
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  The role of the colonic flora in maintaining a healthy large bowel mucosa.

Authors:  M A Chapman
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

3.  Ileal and colonic epithelial metabolism in quiescent ulcerative colitis.

Authors:  M A Chapman; M F Grahn
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

4.  Mucosal enzyme activity for butyrate oxidation; no defect in patients with ulcerative colitis.

Authors:  E S Allan; S Winter; A M Light; A Allan
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

5.  In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis.

Authors:  E J Simpson; M A Chapman; J Dawson; D Berry; I A Macdonald; A Cole
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

6.  Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.

Authors:  M A Chapman; M F Grahn; M A Boyle; M Hutton; J Rogers; N S Williams
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

7.  Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following ischemia-reperfusion injury in the rat.

Authors:  Igor Sukhotnik; Kamal Khateeb; Jorge G Mogilner; Habib Helou; Michael Lurie; Arnold G Coran; Eitan Shiloni
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

8.  Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?

Authors:  Bernd Sido; Cornelia Seel; Achim Hochlehnert; Raoul Breitkreutz; Wulf Dröge
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

9.  Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following acetic acid induced intestinal injury in rats.

Authors:  Forat Swaid; Igor Sukhotnik; Ibrahim Matter; Drora Berkowitz; Christopher Hadjittofi; Yulia Pollak; Alexandra Lavy
Journal:  Nutr Metab (Lond)       Date:  2013-08-07       Impact factor: 4.169

10.  Glutamine attenuates the inhibitory effect of methotrexate on TLR signaling during intestinal chemotherapy-induced mucositis in a rat.

Authors:  Igor Sukhotnik; Yulia Pollak; Arnold G Coran; Janna Pilatov; Jacob Bejar; Jorge G Mogilner; Drora Berkowitz
Journal:  Nutr Metab (Lond)       Date:  2014-04-17       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.